Fusion proteins comprising acid alpha-glucosidase enzymes and methods thereof
CO20260010351A2Pending Publication Date: 2026-10-08DENALI THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CO20260010351
- Authority / Receiving Office
- CO · CO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-19
- Filing Date
- 2026-07-17
- Publication Date
- 2026-10-08
Abstract
Proteins that can be transported across the blood-brain barrier (BBB) and comprise an acid alpha-glucosidase (GAA)-Fc enzyme fusion polypeptide are provided. Certain modalities also provide methods for using such proteins to treat Pompe disease.
Need to check novelty before this filing date? Find Prior Art